Unexpected Turnaround in Alzheimer’s Patient
What an incredible experience it has been.
After a decade of cognitive and functional decline, an 80-year-old woman suffering from advanced Alzheimer’s disease has exhibited remarkable signs of improvement.
With just one dose of an experimental hallucinogenic compound, she found herself capable of communicating far more effectively than she had in years. This is only the beginning of her positive developments.
Alzheimer’s, which impacts millions across America, gradually erodes memory, cognitive skills, and the ability to perform routine tasks. It’s typically seen as a relentless decline, marked by a loss of independence, communication abilities, self-control, mobility, and social engagement.
Currently, treatment options mostly focus on alleviating symptoms rather than fostering meaningful recovery, and the prospect of regaining lost functionality is generally deemed minimal.
Psilocybin, recognized as the psychedelic agent in magic mushrooms, has emerged as a potential remedy not just for depression, anxiety, addiction, and PTSD, but now possibly for Alzheimer’s as well.
In a particular case study, researchers investigated an 80-year-old Japanese American woman grappling with Alzheimer’s. Over the last ten years, her condition had declined severely—she experienced urinary incontinence, spoke in monosyllables, and relied on caregivers for mobility and daily tasks.
After administering 5g of magic mushrooms, she initially showed signs of agitation and perspiration, entering a deep sleep state that suggested loss of consciousness. Yet, by the evening, she began articulating her life experiences in full sentences, recalling details she hadn’t been able to verbalize for years.
At follow-up, astonishing changes were noted. She regained the ability to dress herself and manage her bathroom needs, even at night. Eye contact became more frequent, she remembered past social interactions, responded emotionally to others, and maintained coherent conversations.
Following this, she received another dose of 3g of psilocybin, which further enhanced her verbal skills, sense of humor, and walking ability.
Although the improvements were promising, the study’s authors cautioned that these changes were temporary. The underlying neurodegeneration persisted, highlighting that psilocybin doesn’t reverse the disease. They did not specify the duration of these enhancements.
This research suggests that some skills thought to be permanently lost in advanced dementia might simply be inaccessible, hinting that mushrooms could possibly unlock them, even if just for a fleeting duration.
However, a significant limitation of this study is that it was based on a single patient.
Previous findings have indicated that psilocybin can help create new neural connections and influence serotonin receptors in the brain, areas that govern cognition, mood, and perception. Some studies have even found that the benefits of psilocybin can last up to five years after a single application.
The success of magic mushrooms has inspired many to adopt mood-enhancing microdoses throughout their day. Yet, this trend isn’t without risks—there are well-documented concerns about adverse experiences and potential hallucinations, especially for individuals with a history of mental health disorders.
Additionally, there’s always the possibility of accidents stemming from altered perceptions, and the worst-case scenarios might lead to psychosis, particularly in those with pre-existing mental health conditions.
